Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02722538
Recruitment Status : Active, not recruiting
First Posted : March 30, 2016
Last Update Posted : August 26, 2019
Sponsor:
Information provided by (Responsible Party):
Taris Biomedical LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : June 2019
Estimated Study Completion Date : October 2019